Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals, Inc. (CRVS) stock — financials & valuation

Key numbers for Corvus Pharmaceuticals, Inc. (CRVS): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 39/100 — a percentile rank of Corvus Pharmaceuticals, Inc.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.

Is Corvus Pharmaceuticals, Inc. overvalued? P/B looks fair vs its 5-year range.

Independent of the events above — derived from Corvus Pharmaceuticals, Inc.’s own financial statements and shown as context, never as advice.